Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDMoleculin Biotech, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$0.56 | -$0.56 | -$0.56 |
| Q2 2025 | 2 | -$0.45 | -$0.41 | -$0.43 |
| Q3 2025 | 2 | -$7.57 | -$5.27 | -$6.58 |
| Q4 2025 | 2 | -$5.49 | -$3.25 | -$4.38 |
| Q1 2026 | 1 | -$11.25 | -$11.25 | -$11.25 |
| Q2 2026 | 1 | -$10.75 | -$10.75 | -$10.75 |
| Q3 2026 | 1 | -$10.75 | -$10.75 | -$10.75 |
| Q4 2026 | 1 | -$11.25 | -$11.25 | -$11.25 |
Moleculin Biotech, Inc. Earnings Date And Information
Moleculin Biotech, Inc. last posted its earnings results on Thursday, November 13th, 2025. The company reported $-3.25 earnings per share for the quarter, topping analysts' consensus estimates of $-5 by $1.75. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Moleculin Biotech, Inc. has generated $-158 earnings per share over the last year ($-158 diluted earnings per share) and currently has a price-to-earnings ratio of -0.28. Moleculin Biotech, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, March 20th, 2026 based on prior year's report dates.
Moleculin Biotech, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/13/2025 | Q3 2025 | -$5.00 | -$17.00 | -12 | $0 | $0 |
| 08/12/2025 | Q2 2025 | -$0.39 | -$12.25 | -11.86 | $0 | $0 |
| 05/13/2025 | Q1 2025 | -$0.71 | -$1,722.00 | -1721.29 | $0 | $0 |
| 03/21/2025 | Q4 2024 | -$1.54 | -$14.00 | -12.46 | $63.00 K | $0 |
| 11/08/2024 | Q3 2024 | N/A | -$71.25 | N/A | $0 | $0 |
| 08/13/2024 | Q2 2024 | -$2.10 | -$42.50 | -40.4 | $0 | $0 |
| 05/10/2024 | Q1 2024 | -$3.59 | -$50.50 | -46.91 | N/A | $0 |
| 03/22/2024 | Q4 2023 | -$3.05 | -$128.25 | -125.2 | N/A | $0 |
| 11/13/2023 | Q3 2023 | -$3.15 | -$70.50 | -67.35 | N/A | $0 |
| 08/10/2023 | Q2 2023 | N/A | -$75.50 | N/A | N/A | $0 |
| 05/10/2023 | Q1 2023 | N/A | -$96.50 | N/A | N/A | $0 |
| 03/22/2023 | Q4 2022 | -$4.20 | -$73.75 | -69.55 | N/A | $0 |
| 11/10/2022 | Q3 2022 | -$4.05 | -$112.25 | -108.2 | N/A | $0 |
| 08/12/2022 | Q2 2022 | N/A | -$89.00 | N/A | N/A | $0 |
| 05/11/2022 | Q1 2022 | -$3.15 | -$87.50 | -84.35 | N/A | $0 |
| 03/24/2022 | Q4 2021 | N/A | -$37.00 | N/A | N/A | $0 |
| 11/10/2021 | Q3 2021 | N/A | -$57.50 | N/A | N/A | $0 |
| 08/11/2021 | Q2 2021 | N/A | -$56.00 | N/A | N/A | $0 |
| 05/12/2021 | Q1 2021 | -$3.90 | -$76.50 | -72.6 | $49 | $0 |
| 03/24/2021 | Q4 2020 | -$0.58 | -$85.75 | -85.17 | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Moleculin Biotech, Inc. Earnings: FAQ's
Moleculin Biotech, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, March 20th, 2026 based offlast year's report dates.
In the previous quarter, Moleculin Biotech, Inc. (:MBRX) reported $-3.25 earnings per share (EPS) to beat the analysts' consensus estimate of $-5 by $1.75.
The conference call for Moleculin Biotech, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Moleculin Biotech, Inc.'s latest earnings report can be read online.
Moleculin Biotech, Inc. (:MBRX) has a recorded net income of $-21,763,000.Moleculin Biotech, Inc. has generated $-158 earnings per share over the last four quarters.
Moleculin Biotech, Inc. (:MBRX) has a price-to-earnings ratio of -0.28 and price/earnings-to-growth ratio is -0.09.